of the subject compound which is preferably from about 0 01 mg to about 200 mg more preferably from about 0 1 mg to about 50 mg more preferably still from about d0 5 mg to about 25 mg also preferably from about 1 mg to about 10 mg the pharmaceutically acceptable carrier suitable for the preparation of unit dosage forms for peroral administration are well known in the art peroral compositions also include liquid solutions emulsions suspensions and the like the pharmaceutically acceptable carriers suitable for preparation of such compositions are well known in the art such liquid oral compositions preferably comprise from about 0 001 to about 5 of the subject compound more preferably from about 0 01 to about 0 5 other compositions useful for attaining systemic delivery of the subject compounds include sublingual and buccal dosage forms such compositions typically comprise soluble filler substances and binders as well as optional glidants lubricants sweeteners colorants antioxidants and flavoring agents disclosed above may also be included preferred compositions of this invention include aqueous solutions comprising a safe and effective amount of a subject compound intended for topical including ocular or intranasal administration such preferred compositions of this invention include aqueous solutions suspensions and dry powders comprising a safe and effective amount of a subject compound which.